Theory Paper IDrNB Cardiology – Theory Notes
GUCH (GROWN-UP CONGENITAL HEART DISEASE) / ACHD
ITERMINOLOGY AND THE EPIDEMIOLOGICAL SHIFT (“THE SILVER TSUNAMI”)
- Standardized Terminology: The historical European term GUCH (Grown-Up Congenital Heart Disease) has been replaced in contemporary international guidelines (2020 ESC Guidelines and 2018 AHA/ACC Guidelines) by ACHD (Adult Congenital Heart Disease).
- The Demographic Inversion: Due to transformative advances in neonatal cardiac surgery, pediatric intensive care, and interventional cardiology since the 1970s and 1980s, over 90 percent of children born with CHD now survive into adulthood. Consequently, adults living with CHD (approx. 60 to 65 percent of the total CHD population) now substantially outnumber children with CHD.
- The “Double-Hit” Aging Paradigm: As ACHD survivors reach their 50s, 60s, and 70s, acquired adult cardiovascular diseases—specifically atherosclerotic Coronary Artery Disease, Systemic Hypertension, Type 2 Diabetes, Obesity, and Chronic Kidney Disease—superimpose on residual congenital hemodynamic lesions, accelerating heart failure and arrhythmias.
IITHE FOUR ARCHETYPAL ACHD LESIONS AND THEIR ADULT RESIDUA
AAtrial Septal Defect (ASD)
- Epidemiology: The most common congenital heart defect first diagnosed in adulthood (accounting for 25 to 30 percent of newly diagnosed ACHD).
- Anatomical Subtypes: Ostium Secundum (75 to 80 percent) (central fossa ovalis; amenable to percutaneous device closure), Ostium Primum (15 percent) (partial AVSD; associated with cleft anterior mitral leaflet, left axis deviation, and Trisomy 21; requires surgery), Sinus Venosus (5 to 10 percent) (associated with partial anomalous pulmonary venous connection [PAPVC]; repaired surgically or via covered SVC stent in selected superior SV-ASDs), and Unroofed Coronary Sinus (less than 1 percent).
- Clinical Hallmarks and Adult Complications: Wide, fixed splitting of S2, incomplete or complete RBBB (with the crochetage sign, a notch near the apex of the R wave in inferior leads), right heart volume overload, Atrial Flutter / Atrial Fibrillation (increasing sharply after age 40), paradoxical thromboembolism, and pulmonary arterial hypertension (5 to 10 percent).
BRepaired Tetralogy of Fallot (rTOF)
- Epidemiology: The most common repaired cyanotic congenital heart defect surviving to adulthood.
- The Defining Adult Hemodynamic Sequel: Childhood relief of RVOT obstruction (particularly via a transannular patch) disrupts pulmonary valve integrity, resulting in chronic severe, free Pulmonary Regurgitation (PR) (characterized by a low-pitched, early-terminating diastolic murmur due to low PA pressure). Decades of severe PR cause progressive Right Ventricular (RV) dilation, RV systolic dysfunction, functional Tricuspid Regurgitation, right heart failure, and scar-related Sustained Monomorphic Ventricular Tachycardia / Sudden Cardiac Death.
- Indications for Pulmonary Valve Replacement (TPVR or Surgical PVR — ESC 2020):
- Symptomatic Patients (Class I): Severe PR (CMR regurgitant fraction greater than 30 to 40 percent) and/or at least moderate RVOT obstruction with exercise intolerance or heart failure symptoms.
- Asymptomatic Patients (Class IIa — Volumetric CMR Triggers): Performed before irreversible RV remodeling when any of the following is reached: progressive RV dilation to RV End-Diastolic Volume Index (RVEDVi) of 160 mL/m2 or greater or RV End-Systolic Volume Index (RVESVi) of 80 mL/m2 or greater, progressive RV systolic dysfunction, progressive moderate-to-severe Tricuspid Regurgitation, RVOT obstruction with RV systolic pressure greater than 80 mmHg, or sustained arrhythmias.
CCoarctation of the Aorta (CoA)
- Clinical Presentation: Discrete narrowing at the aortic isthmus (just distal to the left subclavian artery at the ligamentum arteriosum), presenting in young adults with secondary upper-limb hypertension, radio-femoral pulse delay, a systolic blood pressure gradient of 20 mmHg or greater between upper and lower extremities, interscapular continuous/systolic collateral murmurs, and inferior rib notching of the 3rd to 8th ribs (Roesler sign) plus the “Figure-of-3” sign on chest X-ray.
- Classic Associations and Late Sequelae: Associated with Bicuspid Aortic Valve (50 to 85 percent), Turner Syndrome (45,X), intracranial Circle of Willis berry aneurysms (up to 10 percent), Shone complex, and premature coronary artery disease. Even after successful childhood repair, 30 to 50 percent develop chronic systemic hypertension, recoarctation (treated primarily via endovascular covered stent implantation [Class I] in adults when peak-to-peak catheter gradient is 20 mmHg or greater), or patch pseudoaneurysm.
DTransposition of the Great Arteries (d-TGA and ccTGA / L-TGA)
- Complete d-TGA (Ventriculoarterial Discordance):
- Historical Atrial Switch Cohort (Mustard or Senning Operation — 1960s to 1980s): Intra-atrial baffles redirected venous return while leaving the morphological Right Ventricle as the Systemic Ventricle pumping into the aorta; adult complications include progressive Systemic RV Failure, severe systemic Tricuspid Regurgitation, baffle leaks or SVC/IVC baffle stenosis, sinus node dysfunction, and Intra-Atrial Reentrant Tachycardia (IART).
- Contemporary Arterial Switch Cohort (Jatene Operation — 1980s onward): Restores the morphological Left Ventricle as the systemic pump; adult residua are distinct: supravalvular pulmonary artery stenosis (after the LeCompte maneuver), neoaortic root dilation and neoaortic regurgitation, and reimplanted coronary artery ostial stenosis/kinking.
- Congenitally Corrected TGA (ccTGA / L-TGA — Atrioventricular and Ventriculoarterial Discordance): Acyanotic (“double discordance”) lesion in which the Systemic Morphological Right Ventricle inevitably fails in the 4th to 5th decade (often compounded by an Ebstein-like malformation of the systemic tricuspid valve), accompanied by an abnormally positioned anterior AV node that carries a 2 percent per year cumulative risk of spontaneous Complete Heart Block.
| ACHD Lesion | Primary Adult Hemodynamic Sequel | Key Diagnostic / Interventional Trigger (ESC 2020) |
|---|---|---|
| Repaired Tetralogy of Fallot | Chronic Severe Pulmonary Regurgitation -> RV dilation & scar VT | TPVR / Surgical PVR: Symptomatic (Class I); or asymptomatic with CMR RVEDVi >=160 mL/m2 or RVESVi >=80 mL/m2 (Class IIa) |
| Mustard/Senning d-TGA & ccTGA | Failing Systemic Right Ventricle + systemic TR + IART / CHB | Baffle stenting; early CRT for RV pacing; TV replacement before systemic RVEF falls <40%; SGLT2i/ARNI; heart transplant |
| Coarctation of the Aorta | Chronic hypertension, recoarctation, aortic aneurysm, BAV | Covered Stent Implantation (Class I) if invasive peak-to-peak gradient >=20 mmHg (or <20 mmHg with collaterals/HTN) |
| Eisenmenger Syndrome | Irreversible PVOD (PVR >=5 WU) with R-to-L shunt | Bosentan (Class I) + PDE-5i; avoid defect closure (Class III), pregnancy (mWHO IV), and routine phlebotomy |
IIICONTEMPORARY PARADIGM SHIFTS IN ACHD CARE (2020–2026)
- Heart Failure as the Leading Cause of Mortality: Heart failure has overtaken perioperative mortality and sudden death as the number one cause of death in adult CHD. While conventional HFrEF trials of ACE inhibitors/ARBs (e.g., VAL-SERVE with valsartan) and beta-blockers showed neutral primary endpoints in Systemic Right Ventricle cohorts, observational cohorts of SGLT2 inhibitors and Sacubitril/Valsartan (ARNI) in systemic RV patients report improvements in NT-proBNP, functional class, and exercise capacity, though randomized evidence is still awaited.
- The Transcatheter Revolution (Avoiding Repeat Sternotomies):
- Transcatheter Pulmonary Valve Replacement (TPVR): Balloon-expandable valves (Melody and Edwards SAPIEN 3) for surgical RV-to-PA conduits/bioprostheses and dedicated self-expanding native/patched RVOT platforms (Medtronic Harmony and Edwards Alterra Adaptive Prestent) allow percutaneous valve replacement even in large, dilated native transannular-patched RVOTs.
- Transcatheter Sinus Venosus ASD and Baffle/Fontan Interventions: Covered stent correction of superior sinus venosus ASDs, stenting of Mustard/Senning baffle stenoses, and percutaneous lymphatic embolization in failing Fontans.
- Cardiac MRI (CMR) as the Volumetric Gold Standard (Class I): Because echocardiographic windows are restricted after multiple sternotomies and cannot accurately quantify the crescentic right ventricle, serial CMR is Class I mandatory to quantify RVEDVi, RVESVi, RVEF, pulmonary regurgitant fraction, aortic dimensions, and myocardial fibrosis (LGE).
- Proactive Arrhythmia and Sudden Death Prevention:
- Early 3D Catheter Ablation Over Chronic Amiodarone: Because long-term Amiodarone in young ACHD adults causes high rates of thyroid dysfunction (especially in women and Fontan/cyanotic patients), pulmonary fibrosis, and hepatotoxicity, 3D electroanatomical catheter ablation in an experienced ACHD-EP center is preferred for IART and VT (targeting slow-conduction anatomical isthmuses between the VSD patch/ventriculotomy scar and pulmonary/tricuspid annuli in rTOF).
- Risk Stratification for Primary-Prevention ICD in Repaired TOF (Class IIa): Indicated in rTOF patients with multiple risk factors: LV dysfunction, non-sustained symptomatic VT, QRS duration of 180 ms or greater (the classic Gatzoulis mechano-electrical interaction marker), extensive RV scarring/LGE on CMR, or inducible sustained VT on EP study.
- Pregnancy Risk Stratification (mWHO Class IV — Absolute Contraindications, Class III): Pregnancy is strictly contraindicated in Pulmonary Arterial Hypertension of any etiology (including Eisenmenger Syndrome), severe systemic ventricular dysfunction (LVEF less than 30 percent or NYHA III–IV), severe symptomatic Aortic or Mitral Stenosis, Marfan syndrome with aortic root greater than 45 mm (or BAV greater than 50 mm), severe unoperated Coarctation, and Complicated/Failing Fontan.
- Specialized Hub-and-Spoke Care Mandate (Class I): Every patient with moderate or complex ACHD must undergo structured transition from pediatric care and receive lifelong management at a multidisciplinary Specialist ACHD Center.
Key references
- Baumgartner H, De Backer J, Babu-Narayan SV, et al.: 2020 ESC Guidelines for the management of adult congenital heart disease, European Heart Journal, 2020.
- Stout KK, Daniels CJ, Aboulhosn JA, et al.: 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease, Circulation, 2019.
- Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al.: 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy, European Heart Journal, 2018.
- Gatzoulis MA, Balaji S, Webber SA, et al.: Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study, The Lancet, 2000.
meritmedscript.comDr. Sidhartha Mullapudi
